Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Impact of the embryonic obesogenic environment on programming of cardiovascular diseases across the life course

Project description

The relationship between obese parents and cardiovascular disease in offspring

Overweight and obesity, growing public health threats, are among the most important factors increasing the risk of cardiovascular disease and evidence suggests maternal obesity can affect cardiac metabolic programming in utero and cardiovascular dysfunction of offspring later in life. More than half of pregnancies arise in couples in which both parents are overweight or obese. The ERC-funded OBESE-EMBRYO project aims to investigate whether the embryonic environment induced by these prospective parents increases the likelihood of placental and embryonic programming of cardiovascular diseases during the life of the offspring. The project will use metabolomics, imaging and placental-miRNA-studies in embryonic, adult and intergenerational studies, leading to an AI-supported predictive model.

Objective

>50% of all pregnancies occur in couples with overweight or obesity, leading to tremendous risks for pregnancy and long-term offspring cardiovascular complications. My hypothesis is that an embryonic obesogenic environment, induced by the mother and father-to-be, predisposes to placental and embryonic programming of cardiovascular diseases across the life course. This leads to the intergenerational cycle of the cardiovascular disease epidemic. Lifestyle interventions in pregnancy are emerging, but unsuccessful in improving pregnancy or offspring cardiovascular outcomes due to inadequate timing, unclear intervention targets and unpredictable outcomes. OBESE-EMBRYO aims to radically improve care for overweight and obese parents-to-be by targeting the embryonic obesogenic environment to prevent development of cardiovascular diseases in offspring. To fulfil this mission, OBESE-EMBRYO will provide crucial insights for evidence-based, personalized, prevention and intervention strategies from preconception onwards. Beyond state-of-the-art aspects: 1) First population-based study on preconception and early-pregnancy as critical periods for adverse effects of an embryonic obesogenic environment, induced by the mother and father-to-be; 2) Intergenerational metabolism studies using metabolomics and oral-glucose-tolerance-tests to identify unknown metabolic pathways; 3) Cutting-edge imaging studies of cardiovascular development from embryonic life into adulthood to identify unknown developmental adaptations; 4) Longitudinal, repeated, placental-miRNA-studies throughout the first trimester, with an integrated approach to address replication, tissue specificity, functionality; 5) Translation of results into prediction models for offspring cardiovascular complications using Artificial-Intelligence and an evidence-based clinical support system for overweight and obese parents-to-be. Expected results will have great population impact on cardiovascular health in future generations.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-STG

See all projects funded under this call

Host institution

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Net EU contribution
€ 1 499 998,00
Address
DR MOLEWATERPLEIN 40
3015 GD Rotterdam
Netherlands
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 998,00

Beneficiaries (1)